• Wegovy Breakthrough: FDA Resolves Shortage, Reveals New Insights on Weight Loss and Medical Innovation

  • Apr 14 2025
  • Length: 4 mins
  • Podcast

Wegovy Breakthrough: FDA Resolves Shortage, Reveals New Insights on Weight Loss and Medical Innovation

Listen for free

View show details

  • Summary

  • # Wegovy Breakthrough: FDA Shortage Resolution & New Developments | Quiet Please Podcast

    Explore the latest developments in the Wegovy weight loss revolution with host Alexandra Reeves. This episode unpacks the FDA's recent resolution of Wegovy shortages, making this groundbreaking obesity medication more accessible to patients nationwide. Learn about Novo Nordisk's extended savings program reducing costs to $499/month for eligible uninsured patients—a significant drop from the $1,349 list price.

    We dive into the scientific advancements with the STEP UP study revealing a high-dose Wegovy option achieving 20.7% weight loss, surpassing the standard dose. The episode also examines the growing legal challenges with over 1,500 cases now in multi-district litigation regarding potential side effects.

    From its economic impact boosting Denmark's economy to its cultural significance in Hollywood and beyond, discover how Wegovy is reshaping our understanding of obesity treatment, healthcare accessibility, and pharmaceutical innovation. Subscribe to Quiet Please for ongoing coverage of this medical breakthrough that generated $9.4 billion in revenue last year alone.
    Show more Show less
Show more Show less
adbl_web_global_use_to_activate_webcro768_stickypopup

What listeners say about Wegovy Breakthrough: FDA Resolves Shortage, Reveals New Insights on Weight Loss and Medical Innovation

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available